Logo image of SPNS

SAPIENS INTERNATIONAL CORP (SPNS) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:SPNS - KYG7T16G1039 - Common Stock

43.44 USD
-0.03 (-0.07%)
Last: 12/15/2025, 5:27:20 PM
43.44 USD
0 (0%)
After Hours: 12/15/2025, 5:27:20 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SPNS. SPNS was compared to 280 industry peers in the Software industry. While SPNS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. SPNS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year SPNS was profitable.
In the past year SPNS had a positive cash flow from operations.
Each year in the past 5 years SPNS has been profitable.
Each year in the past 5 years SPNS had a positive operating cash flow.
SPNS Yearly Net Income VS EBIT VS OCF VS FCFSPNS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

1.2 Ratios

SPNS has a Return On Assets of 8.65%. This is amongst the best in the industry. SPNS outperforms 82.14% of its industry peers.
SPNS has a better Return On Equity (12.53%) than 77.14% of its industry peers.
SPNS's Return On Invested Capital of 10.86% is amongst the best of the industry. SPNS outperforms 86.07% of its industry peers.
SPNS had an Average Return On Invested Capital over the past 3 years of 11.69%. This is in line with the industry average of 10.81%.
Industry RankSector Rank
ROA 8.65%
ROE 12.53%
ROIC 10.86%
ROA(3y)9.12%
ROA(5y)7.74%
ROE(3y)14.05%
ROE(5y)12.52%
ROIC(3y)11.69%
ROIC(5y)9.95%
SPNS Yearly ROA, ROE, ROICSPNS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 11.40%, SPNS is doing good in the industry, outperforming 72.86% of the companies in the same industry.
In the last couple of years the Profit Margin of SPNS has grown nicely.
SPNS has a Operating Margin of 13.72%. This is in the better half of the industry: SPNS outperforms 80.00% of its industry peers.
In the last couple of years the Operating Margin of SPNS has grown nicely.
SPNS has a worse Gross Margin (44.30%) than 72.14% of its industry peers.
SPNS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.72%
PM (TTM) 11.4%
GM 44.3%
OM growth 3Y8.52%
OM growth 5Y6.49%
PM growth 3Y9.13%
PM growth 5Y10.59%
GM growth 3Y2.52%
GM growth 5Y2%
SPNS Yearly Profit, Operating, Gross MarginsSPNS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SPNS is creating some value.
Compared to 1 year ago, SPNS has more shares outstanding
The number of shares outstanding for SPNS has been increased compared to 5 years ago.
SPNS has a better debt/assets ratio than last year.
SPNS Yearly Shares OutstandingSPNS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
SPNS Yearly Total Debt VS Total AssetsSPNS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

SPNS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.28
Altman-Z N/A
ROIC/WACC1.24
WACC8.79%
SPNS Yearly LT Debt VS Equity VS FCFSPNS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.3 Liquidity

SPNS has a Current Ratio of 1.52. This is a normal value and indicates that SPNS is financially healthy and should not expect problems in meeting its short term obligations.
SPNS has a Current ratio of 1.52. This is comparable to the rest of the industry: SPNS outperforms 45.71% of its industry peers.
SPNS has a Quick Ratio of 1.52. This is a normal value and indicates that SPNS is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.52, SPNS is in line with its industry, outperforming 46.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.52
SPNS Yearly Current Assets VS Current LiabilitesSPNS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

4

3. Growth

3.1 Past

The earnings per share for SPNS have decreased by -1.37% in the last year.
The Earnings Per Share has been growing by 13.51% on average over the past years. This is quite good.
Looking at the last year, SPNS shows a small growth in Revenue. The Revenue has grown by 4.71% in the last year.
Measured over the past years, SPNS shows a quite strong growth in Revenue. The Revenue has been growing by 10.74% on average per year.
EPS 1Y (TTM)-1.37%
EPS 3Y7.3%
EPS 5Y13.51%
EPS Q2Q%-2.7%
Revenue 1Y (TTM)4.71%
Revenue growth 3Y5.57%
Revenue growth 5Y10.74%
Sales Q2Q%11.16%

3.2 Future

Based on estimates for the next years, SPNS will show a small growth in Earnings Per Share. The EPS will grow by 6.07% on average per year.
The Revenue is expected to grow by 7.22% on average over the next years.
EPS Next Y0.96%
EPS Next 2Y4.71%
EPS Next 3Y6.07%
EPS Next 5YN/A
Revenue Next Year6.35%
Revenue Next 2Y6.67%
Revenue Next 3Y7.22%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
SPNS Yearly Revenue VS EstimatesSPNS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
SPNS Yearly EPS VS EstimatesSPNS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 30.17, SPNS can be considered very expensive at the moment.
Based on the Price/Earnings ratio, SPNS is valued a bit cheaper than 64.64% of the companies in the same industry.
SPNS is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.55, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 26.95, which means the current valuation is very expensive for SPNS.
Based on the Price/Forward Earnings ratio, SPNS is valued a bit cheaper than the industry average as 63.21% of the companies are valued more expensively.
SPNS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 30.17
Fwd PE 26.95
SPNS Price Earnings VS Forward Price EarningsSPNS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SPNS indicates a somewhat cheap valuation: SPNS is cheaper than 75.36% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SPNS indicates a somewhat cheap valuation: SPNS is cheaper than 67.14% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 34.52
EV/EBITDA 23.69
SPNS Per share dataSPNS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SPNS does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of SPNS may justify a higher PE ratio.
PEG (NY)31.45
PEG (5Y)2.23
EPS Next 2Y4.71%
EPS Next 3Y6.07%

4

5. Dividend

5.1 Amount

SPNS has a Yearly Dividend Yield of 1.36%. Purely for dividend investing, there may be better candidates out there.
SPNS's Dividend Yield is rather good when compared to the industry average which is at 1.91. SPNS pays more dividend than 93.57% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 1.87, SPNS is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.36%

5.2 History

The dividend of SPNS is nicely growing with an annual growth rate of 21.00%!
SPNS has been paying a dividend for at least 10 years, so it has a reliable track record.
The dividend of SPNS decreased in the last 3 years.
Dividend Growth(5Y)21%
Div Incr Years2
Div Non Decr Years2
SPNS Yearly Dividends per shareSPNS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

60.73% of the earnings are spent on dividend by SPNS. This is not a sustainable payout ratio.
The dividend of SPNS is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP60.73%
EPS Next 2Y4.71%
EPS Next 3Y6.07%
SPNS Yearly Income VS Free CF VS DividendSPNS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
SPNS Dividend Payout.SPNS Dividend Payout, showing the Payout Ratio.SPNS Dividend Payout.PayoutRetained Earnings

SAPIENS INTERNATIONAL CORP

NASDAQ:SPNS (12/15/2025, 5:27:20 PM)

After market: 43.44 0 (0%)

43.44

-0.03 (-0.07%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-13 2025-11-13/bmo
Earnings (Next)02-16 2026-02-16/bmo
Inst Owners44.65%
Inst Owner Change21.4%
Ins Owners1.55%
Ins Owner ChangeN/A
Market Cap2.43B
Revenue(TTM)564.33M
Net Income(TTM)64.33M
Analysts46.67
Price Target37.99 (-12.55%)
Short Float %1.98%
Short Ratio1.24
Dividend
Industry RankSector Rank
Dividend Yield 1.36%
Yearly Dividend0.57
Dividend Growth(5Y)21%
DP60.73%
Div Incr Years2
Div Non Decr Years2
Ex-Date04-07 2025-04-07 (0.36)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.06%
Min EPS beat(2)1.71%
Max EPS beat(2)4.41%
EPS beat(4)4
Avg EPS beat(4)2.21%
Min EPS beat(4)0.43%
Max EPS beat(4)4.41%
EPS beat(8)7
Avg EPS beat(8)1.55%
EPS beat(12)9
Avg EPS beat(12)0.99%
EPS beat(16)11
Avg EPS beat(16)1.29%
Revenue beat(2)1
Avg Revenue beat(2)-0.04%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)0.75%
Revenue beat(4)1
Avg Revenue beat(4)-1.3%
Min Revenue beat(4)-3.15%
Max Revenue beat(4)0.75%
Revenue beat(8)1
Avg Revenue beat(8)-1.9%
Revenue beat(12)2
Avg Revenue beat(12)-1.62%
Revenue beat(16)2
Avg Revenue beat(16)-2.03%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)3.02%
EPS NQ rev (3m)3.02%
EPS NY rev (1m)2.46%
EPS NY rev (3m)2.46%
Revenue NQ rev (1m)-0.69%
Revenue NQ rev (3m)-0.69%
Revenue NY rev (1m)0.28%
Revenue NY rev (3m)0.28%
Valuation
Industry RankSector Rank
PE 30.17
Fwd PE 26.95
P/S 4.3
P/FCF 34.52
P/OCF 30.36
P/B 4.73
P/tB 29.4
EV/EBITDA 23.69
EPS(TTM)1.44
EY3.31%
EPS(NY)1.61
Fwd EY3.71%
FCF(TTM)1.26
FCFY2.9%
OCF(TTM)1.43
OCFY3.29%
SpS10.1
BVpS9.19
TBVpS1.48
PEG (NY)31.45
PEG (5Y)2.23
Graham Number17.25
Profitability
Industry RankSector Rank
ROA 8.65%
ROE 12.53%
ROCE 13.41%
ROIC 10.86%
ROICexc 12.66%
ROICexgc 97.17%
OM 13.72%
PM (TTM) 11.4%
GM 44.3%
FCFM 12.46%
ROA(3y)9.12%
ROA(5y)7.74%
ROE(3y)14.05%
ROE(5y)12.52%
ROIC(3y)11.69%
ROIC(5y)9.95%
ROICexc(3y)18.71%
ROICexc(5y)15.75%
ROICexgc(3y)280.93%
ROICexgc(5y)294.09%
ROCE(3y)14.42%
ROCE(5y)12.28%
ROICexgc growth 3Y-14.08%
ROICexgc growth 5Y38.54%
ROICexc growth 3Y17.66%
ROICexc growth 5Y14.5%
OM growth 3Y8.52%
OM growth 5Y6.49%
PM growth 3Y9.13%
PM growth 5Y10.59%
GM growth 3Y2.52%
GM growth 5Y2%
F-Score5
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.28
Debt/EBITDA 0
Cap/Depr 42.92%
Cap/Sales 1.71%
Interest Coverage 250
Cash Conversion 80.05%
Profit Quality 109.33%
Current Ratio 1.52
Quick Ratio 1.52
Altman-Z N/A
F-Score5
WACC8.79%
ROIC/WACC1.24
Cap/Depr(3y)44.6%
Cap/Depr(5y)44.64%
Cap/Sales(3y)1.85%
Cap/Sales(5y)2.21%
Profit Quality(3y)92.81%
Profit Quality(5y)112.61%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.37%
EPS 3Y7.3%
EPS 5Y13.51%
EPS Q2Q%-2.7%
EPS Next Y0.96%
EPS Next 2Y4.71%
EPS Next 3Y6.07%
EPS Next 5YN/A
Revenue 1Y (TTM)4.71%
Revenue growth 3Y5.57%
Revenue growth 5Y10.74%
Sales Q2Q%11.16%
Revenue Next Year6.35%
Revenue Next 2Y6.67%
Revenue Next 3Y7.22%
Revenue Next 5YN/A
EBIT growth 1Y-8.06%
EBIT growth 3Y14.56%
EBIT growth 5Y17.93%
EBIT Next Year4.61%
EBIT Next 3Y7.35%
EBIT Next 5YN/A
FCF growth 1Y52.74%
FCF growth 3Y1.68%
FCF growth 5Y8.06%
OCF growth 1Y44.86%
OCF growth 3Y0.69%
OCF growth 5Y4.44%

SAPIENS INTERNATIONAL CORP / SPNS FAQ

What is the fundamental rating for SPNS stock?

ChartMill assigns a fundamental rating of 5 / 10 to SPNS.


What is the valuation status for SPNS stock?

ChartMill assigns a valuation rating of 4 / 10 to SAPIENS INTERNATIONAL CORP (SPNS). This can be considered as Fairly Valued.


How profitable is SAPIENS INTERNATIONAL CORP (SPNS) stock?

SAPIENS INTERNATIONAL CORP (SPNS) has a profitability rating of 7 / 10.


What are the PE and PB ratios of SAPIENS INTERNATIONAL CORP (SPNS) stock?

The Price/Earnings (PE) ratio for SAPIENS INTERNATIONAL CORP (SPNS) is 30.17 and the Price/Book (PB) ratio is 4.73.


Can you provide the expected EPS growth for SPNS stock?

The Earnings per Share (EPS) of SAPIENS INTERNATIONAL CORP (SPNS) is expected to grow by 0.96% in the next year.